Top
ATAD2B has not been detected as a mutational cancer driver

ATAD2B
Ensembl id ENSG00000119778
Mutated samples
Coding Sequence 69 (1.0%)
Protein Affecting 50 (0.7%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all ATAD2B gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Breast carcinoma No 11 11 0.96
Cutaneous melanoma No 9 8 2.17
Head and neck squamous cell carcinoma No 11 8 2.13
Uterine corpus endometrioid carcinoma No 5 4 1.74
Lung adenocarcinoma No 4 3 0.77
Lung squamous cell carcinoma No 3 3 1.72
Colorectal adenocarcinoma No 3 3 1.31
Serous ovarian adenocarcinoma No 2 2 0.63
Prostate adenocarcinoma No 1 1 0.41
Hepatocarcinoma No 1 1 1.11
Bladder carcinoma No 2 1 1.02
Medulloblastoma No 2 1 0.48
Renal clear cell carcinoma No 1 1 0.24
Chronic lymphocytic leukemia No 6 1 0.34
Multiple myeloma No 1 1 1.45
Stomach adenocarcinoma No 2 1 0.62
Neuroblastoma No 1 0 0.00
Glioblastoma multiforme No 1 0 0.00
Esophageal carcinoma No 3 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence